Molbio Diagnostics Invests $30 Million in OptraSCAN to Revolutionize Digital Pathology

BioNTech Acquires Chinese Oncology Firm Biotheus for $950M

The Care and Protection of Children Trust

CPCT Launches Groundbreaking Initiative to Provide Lifelong Free Treatment for Children with Spinal Muscular Atrophy (SMA) in Karnataka

Early Comprehensive Genomic Profiling Improves Cancer Treatment Outcomes, Study Shows

EMA Reverses Decision, Recommends Limited Approval for Eisai and Biogen’s Alzheimer’s Drug Leqembi

Exact Sciences Unveils Advances in Multi-Cancer Early Detection with Cancerguard™ Test

MSD and LaNova Medicines Enter Exclusive Global License Agreement for Novel Cancer Therapy, LM-299

Promising CAR T Cell Therapies from BMS and Cabaletta Bio Show Potential for Durable Remission in Severe Lupus

FDA Grants Accelerated Approval to PTC Therapeutics' KEBILIDI™, the First Gene Therapy for AADC Deficiency in the U.S.

Association for Molecular Pathology Publishes Joint Consensus Report on SARS-CoV-2 Genomic Surveillance for Hospitals and Public Health Laboratories

Philips India Unveils Advanced Azurion Imaging System to Revolutionize Cardiac and Neurovascular Care

Tempus AI Study Highlights Benefits of Dual RNA and DNA Sequencing for Advanced Lung Cancer

Ontada and Datavant Partner to Expand Access to Real-World Oncology Data for Accelerated Cancer Innovation

Tempus AI and Flatiron Health Partner to Integrate Genomic Testing into OncoEMR for Enhanced Oncology Care

Flare Therapeutics and Roche Forge Strategic Partnership to Discover Precision Oncology Therapies Targeting Transcription Factors

Home
/
update
/
details

Qure.ai Wins Siemens Healthineers Startup Award 2024 for Advancing Healthcare AI Innovation

NextEdge Admin

12 Aug 2024

2 min 4 sec

Qure.ai, a global leader in healthcare AI, has been honored with the Siemens Healthineers Startup Award 2024. This prestigious accolade celebrates startups that have developed innovative and impactful solutions to healthcare challenges, showcasing strong growth and market potential. Qure.ai's AI-driven technologies have significantly advanced the diagnosis of tuberculosis, stroke, and musculoskeletal conditions, contributing to improved patient outcomes.

Prashant Warier, CEO and Co-founder of Qure.ai, expressed pride in receiving the award and emphasized the value of their partnership with Siemens Healthineers. “To be recognized as a leading innovator in AI-powered healthcare by Siemens Healthineers is a tremendous honor. Their commitment to improving patient outcomes and access to care aligns perfectly with our mission,” he stated. Warier also highlighted the collaboration's potential to enhance access to healthcare and streamline diagnostics globally.

Peter Schardt, Chief Technology Officer at Siemens Healthineers, praised the partnership, noting, “Together, we are accelerating the transformation of smart ideas into impactful healthcare solutions. This award celebrates the exceptional team at Qure.ai, who are driving a healthier future for all.”

Qure.ai’s collaboration with Siemens Healthineers underscores a shared commitment to making healthcare more accessible, equitable, and sustainable worldwide. The award is a testament to Qure.ai's innovative contributions and its potential to continue revolutionizing healthcare through AI-powered solutions.